The healthcare costs generated by people who decline or forget to take their medication for a variety of reasons generate roughly $100 billion in healthcare costs each year. The goal behind AdhereTech’s pill bottle is to whittle that figure down and get at the root reasons why patients aren’t taking their medication. This week it has inked a deal with with wireless provider KORE Telematics, according to a company statement.
KORE specializes in machine-to-machine communications, technology, allowing wireless and wired systems to communicate with other devices of the same type. KORE has worked in the telehealth industry for a few years, according to a spokesman for the company. It initially built its business in logistics.
AdhereTech transmits HIPAA-compliant data from its pill bottle to the cloud. It not only sends text messages or rings users to remind them to take their medicine, but also uses sensors to track how often and when a patient takes their medication. It can also collect feedback on why the patient is not taking their meds and inform doctors.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
AdhereTech, which is a graduate of the Blueprint Health accelerator and a member of StartUp Health, is gearing up for clinical trials this fall. It’s also working with a pharmaceutical company to evaluate its technology next year.
With Walter Reed Army Medical Center, it’s evaluating the pill bottle for patients using Type 2 diabetes medications. It’s also testing the pill bottle using single-dose HIV medication with Weill Cornell Medical College.
